The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.

You can also contact the CTN coordinating centre for additional information:

Study Name on (link is external)
Effect of GS-5745 on FEV1 in Adults With Cystic Fibrosis
Study Drug GS-5745
Type of Study Drug Anti-inflammatory
Study Title A Phase 2b, Dose-Ranging Study of the Effect of GS-5745 on FEV1 in Adult Subjects With Cystic Fibrosis
Study Phase 2b
Study Sponsor Gilead

Link on (link is external)

Participating ECFS-CTN sites Please contact for most recent sitelist
Age 18 Years and older